Olaplex Holdings, Inc. (NASDAQ:OLPX) Shares Sold by Barclays PLC

Barclays PLC lessened its stake in shares of Olaplex Holdings, Inc. (NASDAQ:OLPX) by 3.2% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 310,689 shares of the company’s stock after selling 10,327 shares during the period. Barclays PLC’s holdings in Olaplex were worth $729,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Ballentine Partners LLC acquired a new position in shares of Olaplex during the 3rd quarter worth about $28,000. Cinctive Capital Management LP acquired a new stake in Olaplex in the 3rd quarter valued at about $38,000. Abel Hall LLC raised its holdings in Olaplex by 68.1% in the 3rd quarter. Abel Hall LLC now owns 18,261 shares of the company’s stock valued at $43,000 after acquiring an additional 7,397 shares during the last quarter. Quarry LP acquired a new stake in Olaplex in the 2nd quarter valued at about $33,000. Finally, Vanguard Personalized Indexing Management LLC raised its holdings in Olaplex by 38.9% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 25,819 shares of the company’s stock valued at $40,000 after acquiring an additional 7,235 shares during the last quarter. Institutional investors and hedge funds own 87.37% of the company’s stock.

Olaplex Stock Up 2.6 %

Shares of NASDAQ OLPX opened at $1.58 on Thursday. The company has a 50 day simple moving average of $1.85 and a 200-day simple moving average of $1.98. The company has a market capitalization of $1.05 billion, a P/E ratio of 26.34 and a beta of 2.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 11.84 and a quick ratio of 10.32. Olaplex Holdings, Inc. has a 1 year low of $1.19 and a 1 year high of $2.77.

Olaplex (NASDAQ:OLPX) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.04. The business had revenue of $119.10 million during the quarter, compared to the consensus estimate of $126.51 million. Olaplex had a net margin of 9.78% and a return on equity of 10.50%. The business’s revenue was down 3.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.05 EPS. On average, equities research analysts predict that Olaplex Holdings, Inc. will post 0.11 earnings per share for the current year.

Insider Activity at Olaplex

In related news, Director John P. Bilbrey purchased 51,697 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The shares were purchased at an average cost of $1.75 per share, for a total transaction of $90,469.75. Following the purchase, the director now directly owns 318,418 shares of the company’s stock, valued at $557,231.50. The trade was a 19.38 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 4.20% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Piper Sandler increased their price objective on shares of Olaplex from $1.50 to $2.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Barclays cut their price objective on shares of Olaplex from $2.00 to $1.50 and set an “equal weight” rating for the company in a report on Monday, November 11th. Finally, Telsey Advisory Group reiterated a “market perform” rating and issued a $3.00 price objective on shares of Olaplex in a report on Thursday, November 7th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $2.30.

About Olaplex

Olaplex Holdings, Inc develops, manufactures, and sells hair care products in the United States and internationally. The company offers hair care shampoos and conditioners for use in treatment, maintenance, and protection of hair, as well as oil, moisture mask, and nourishing hair serum. It provides hair care products to professional hair salons, retailers, and everyday consumers.